acetaminophen 300 MG / butalbital 50 MG Oral Tablet
- RxCUI
- 1249617
- RxNorm name
- acetaminophen 300 MG / butalbital 50 MG Oral Tablet
- Display name
- Acetaminophen/Butalbital (Oral Pill)
- Full name
- acetaminophen 300 MG / butalbital 50 MG Oral Tablet
- Term type
- SCD
- Status
- Active
- Strength
- 300-50 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-10-17 23:46:22
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 052012
- Active start
- 052012
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| acetaminophen | 300 MG / 1 EACH | acetaminophen | acetaminophen |
| butalbital | 50 MG / 1 EACH | butalbital | butalbital |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| acetaminophen | 161 |
| butalbital | 19860 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | acetaminophen 300 MG / butalbital 50 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | acetaminophen 300 MG / butalbital 50 MG Oral Tablet | 1 | NAMES |
| RxNorm Synonym | APAP 300 MG / butalbital 50 MG Oral Tablet | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 5 | CODES | |
| RxCUI | 1249617 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 35573-455-02 | 35573-455 | BUTALBITAL AND ACETAMINOPHEN butalbital and acetaminophen | Burel Pharmaceuticals, LLC | ANDA214088 |
| 68682-306-01 | 68682-306 | Butalbital and Acetaminophen Butalbital and Acetaminophen tablets | Oceanside Pharmaceuticals | ANDA090956 |
| 69292-301-01 | 69292-301 | BUTALBITAL AND ACETAMINOPHEN butalbital and acetaminophen | Amici Pharma, Inc. | ANDA214088 |
| 70752-147-10 | 70752-147 | BUTALBITAL and ACETAMINOPHEN BUTALBITAL and ACETAMINOPHEN | QUAGEN PHARMACEUTICALS LLC | ANDA214305 |
| 70752-147-14 | 70752-147 | BUTALBITAL and ACETAMINOPHEN BUTALBITAL and ACETAMINOPHEN | QUAGEN PHARMACEUTICALS LLC | ANDA214305 |
| 81005-123-01 | 81005-123 | BUTALBITAL AND ACETAMINOPHEN butalbital and acetaminophen | Aarkish Pharmaceuticals NJ Inc. | ANDA214955 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA214088 | 35573-455 | BUTALBITAL AND ACETAMINOPHEN butalbital and acetaminophen | ANDA | Burel Pharmaceuticals, LLC |
| ANDA090956 | 68682-306 | Butalbital and Acetaminophen Butalbital and Acetaminophen tablets | ANDA | Oceanside Pharmaceuticals |
| ANDA214305 | 70752-147 | BUTALBITAL and ACETAMINOPHEN BUTALBITAL and ACETAMINOPHEN | ANDA | QUAGEN PHARMACEUTICALS LLC |
| ANDA214955 | 81005-123 | BUTALBITAL AND ACETAMINOPHEN butalbital and acetaminophen | ANDA | Aarkish Pharmaceuticals NJ Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BUTALBITAL AND ACETAMINOPHEN | BUTALBITAL AND ACETAMINOPHEN | Amici Pharma, Inc. | 3280501f-928a-4112-803d-fb9771c86547 | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | 69292-301-01 69292-301 69292030101 1249617 |
| BUTALBITAL AND ACETAMINOPHEN | BUTALBITAL AND ACETAMINOPHEN | Aarkish Pharmaceuticals NJ Inc. | 82fa5151-d5ee-4ad8-ba7c-a2df8a09e1a6 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | 81005-123-01 81005-123 81005012301 1249617 |
| BUTALBITAL AND ACETAMINOPHEN | BUTALBITAL AND ACETAMINOPHEN | Burel Pharmaceuticals, LLC | 0a8a6a16-b23f-45d2-b5d4-540264e74d14 | 2024-10-18 | Boxed warning, Warnings, Adverse reactions | 35573-455-02 35573-455 35573045502 1249617 |
| BUTALBITAL and ACETAMINOPHEN | BUTALBITAL AND ACETAMINOPHEN | QUAGEN PHARMACEUTICALS LLC | 1f0dbe62-6aea-4323-ad25-c2211f919253 | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | 70752-147-10 70752-147-14 70752-147 70752014710 70752014714 1249617 |
| Butalbital and Acetaminophen | BUTALBITAL AND ACETAMINOPHEN TABLETS | Oceanside Pharmaceuticals | d2213ffd-18f6-45f5-9af7-690a977562c4 | 2020-04-02 | Boxed warning, Warnings, Adverse reactions | 68682-306-01 68682-306 68682030601 1249617 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 82fa5151-d5ee-4ad8-ba7c-a2df8a09e1a6 | butalbital 50 MG / acetaminophen 300 MG Oral Tablet [PSN] · acetaminophen 300 MG / butalbital 50 MG Oral Tablet [SCD] · APAP 300 MG / butalbital 50 MG Oral Tablet [SY] | 3 | 6 | Butalbital and Acetaminophen Tablets 50 mg/ 300 mg | 20250617 |
| 669e3bd0-fbd9-423c-8654-a78fe650e3e2 | butalbital 50 MG / acetaminophen 300 MG Oral Tablet [PSN] · acetaminophen 300 MG / butalbital 50 MG Oral Tablet [SCD] · APAP 300 MG / butalbital 50 MG Oral Tablet [SY] | 3 | 6 | Butalbital and Acetaminophen Tablets 50 mg/300 mg | 20190822 |
| 1f0dbe62-6aea-4323-ad25-c2211f919253 | butalbital 50 MG / acetaminophen 300 MG Oral Tablet [PSN] · acetaminophen 300 MG / butalbital 50 MG Oral Tablet [SCD] · APAP 300 MG / butalbital 50 MG Oral Tablet [SY] | 3 | 4 | Butalbital and Acetaminophen Tablets | 20240506 |
| d2213ffd-18f6-45f5-9af7-690a977562c4 | butalbital 50 MG / acetaminophen 300 MG Oral Tablet [PSN] · acetaminophen 300 MG / butalbital 50 MG Oral Tablet [SCD] · APAP 300 MG / butalbital 50 MG Oral Tablet [SY] | 3 | 4 | Butalbital and Acetaminophen Tablets 50 mg/300 mg | 20200402 |
| 0a8a6a16-b23f-45d2-b5d4-540264e74d14 | butalbital 50 MG / acetaminophen 300 MG Oral Tablet [PSN] · acetaminophen 300 MG / butalbital 50 MG Oral Tablet [SCD] · APAP 300 MG / butalbital 50 MG Oral Tablet [SY] | 3 | 3 | Butalbital and Acetaminophen Tablets, 50 mg/325 mg and 50 mg/300 mg Rx only | 20241018 |
| 3280501f-928a-4112-803d-fb9771c86547 | butalbital 50 MG / acetaminophen 300 MG Oral Tablet [PSN] · acetaminophen 300 MG / butalbital 50 MG Oral Tablet [SCD] · APAP 300 MG / butalbital 50 MG Oral Tablet [SY] | 3 | 1 | Butalbital and Acetaminophen Tablets | 20260317 |
| a24ccca7-e347-44e4-b700-1cc54c525bd3 | butalbital 50 MG / acetaminophen 300 MG Oral Tablet [PSN] · acetaminophen 300 MG / butalbital 50 MG Oral Tablet [SCD] · APAP 300 MG / butalbital 50 MG Oral Tablet [SY] | 3 | 1 | Butalbital and Acetaminophen Tablets 50 mg/300 mg | 20200813 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 3280501f-928a-4112-803d-fb9771c86547 | Butalbital and Acetaminophen Tablets | Amici Pharma, Inc. | 20260317 |
| 82fa5151-d5ee-4ad8-ba7c-a2df8a09e1a6 | Butalbital and Acetaminophen Tablets 50 mg/ 300 mg | Aarkish Pharmaceuticals NJ Inc. | AACE Pharmaceuticals, Inc. | 20250617 |
| 0a8a6a16-b23f-45d2-b5d4-540264e74d14 | Butalbital and Acetaminophen Tablets, 50 mg/325 mg and 50 mg/300 mg Rx only | Burel Pharmaceuticals, LLC | 20241018 |
| 1f0dbe62-6aea-4323-ad25-c2211f919253 | Butalbital and Acetaminophen Tablets | QUAGEN PHARMACEUTICALS LLC | 20240506 |
| fc55ae1c-aa76-4c75-a6f2-64fc47a5ceba | Butalbital and Acetaminophen Tablets 50 mg/300 mg | AACE Pharmaceuticals, Inc. | 20221215 |
| 0a8a6a16-b23f-45d2-b5d4-540264e74d14 | Butalbital and Acetaminophen Tablets, 50 mg/325 mg and 50 mg/300 mg Rx only | Burel Pharmaceuticals, LLC | 20221215 |
| adde9439-7399-4706-8237-81ab5658f8f0 | Mayne Pharma | 20221003 | |
| bff2bcb9-5ddf-9c46-9edf-ea17ea4630e5 | Butalbital and Acetaminophen Tablets | Alvogen Inc. | 20211215 |
| a24ccca7-e347-44e4-b700-1cc54c525bd3 | Butalbital and Acetaminophen Tablets 50 mg/300 mg | LGM Pharma Solutions, LLC | 20200813 |
| d2213ffd-18f6-45f5-9af7-690a977562c4 | Butalbital and Acetaminophen Tablets 50 mg/300 mg | Oceanside Pharmaceuticals | LGM Pharma Solutions, LLC | 20200402 |
| 98a517d8-43d6-4920-83e0-b9483864a6b4 | Butalbital and Acetaminophen Tablets 50 mg / 300 mg | Alvogen Inc. | 20200121 |
| 91257639-85a1-404d-bfb1-b63a3f4521e7 | Mikart, LLC | 20200118 | |
| 669e3bd0-fbd9-423c-8654-a78fe650e3e2 | Butalbital and Acetaminophen Tablets 50 mg/300 mg | Nexgen Pharma, Inc. | 20190822 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N02BE | Anilides | ATC1-4 | acetaminophen | |
| FDASPL | D001463 | Barbiturates | CHEM | has_chemical_structure | butalbital |
| FDASPL | N0000175693 | Barbiturate | EPC | has_epc | butalbital |
| MEDRT | D000082 | Acetaminophen | CHEM | has_ingredient | acetaminophen |
| MEDRT | D001463 | Barbiturates | CHEM | has_ingredient | butalbital |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | acetaminophen |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | butalbital |
| MEDRT | D005334 | Fever | DISEASE | may_prevent | acetaminophen |
| MEDRT | D005334 | Fever | DISEASE | may_treat | acetaminophen |
| MEDRT | D005955 | Glucosephosphate Dehydrogenase Deficiency | DISEASE | ci_with | acetaminophen |
| MEDRT | D006261 | Headache | DISEASE | may_treat | butalbital |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_treat | acetaminophen |
| MEDRT | D011164 | Porphyrias | DISEASE | ci_with | butalbital |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | butalbital |
| MEDRT | N0000000105 | Neurotransmitter Transporter Interactions | MOA | has_moa | butalbital |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | acetaminophen |
| MEDRT | N0000175724 | Central Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | butalbital |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | acetaminophen |
| MEDRT | N0000009072 | Hypothalamic Endocrine Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000175725 | Peripheral Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | acetaminophen |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | acetaminophen |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 300 MG / 50 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 3 |
| CODES | ANDA | ANDA090956 |
| CODES | ANDA | ANDA214088 |
| CODES | ANDA | ANDA214305 |
| CODES | ANDA | ANDA214955 |
| CODES | VUID | 4032528 |
| NAMES | Prescribable Synonym | butalbital 50 MG / acetaminophen 300 MG Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |